#United States #Richmond #Alps Dx #Xpressor™ #Atelier™

Alps Dx to Launch Xpressor™ at ADLM 2026

Alps Dx has officially announced an exciting debut: the launch of Xpressor™ at the upcoming ADLM 2026 Annual Meeting. This innovative filtration and capping device is tailored to enhance the preparation of oral fluid samples, promising a more efficient, safer, and consistent methodology within laboratories.

This groundbreaking product directly addresses the persistent challenges faced by forensic and clinical toxicology labs, where traditional manual methods have long dominated the sample handling process. Current practices often involve laborious steps that not only slow down operations but also increase the likelihood of errors—issues that Xpressor™ aims to rectify.

Historically, many laboratories have relied on inefficient practices such as hand-squeezing swabs, changing gloves between samples, manual transfer of materials into separate tubes, and performing time-consuming centrifugation procedures. These methods introduce variations, risk contamination, and heighten the chances of sample loss. Moreover, they complicate turnaround times and adversely affect the functionality of analytical instruments that depend on clean, reliable samples.

Dr. Les Edinboro, co-founder and Chief Scientific Officer of Alps Dx, emphasized the need for improvement in the preanalytical phase of oral fluid testing. He noted, "Preanalytical handling has historically been one of the most time-intensive and inconsistent stages of oral fluid testing. Xpressor was created to give laboratories a straightforward way to reduce manual, error-prone steps and protect sample integrity without altering established workflows. By allowing filtration to occur within the original collection tube, we are helping laboratories operate with greater consistency and confidence."

The Xpressor™ device simplifies the preparation process to just two easy steps: a technician opens the tube and inserts the Xpressor filter and cap. Early independent studies suggest that this streamlined procedure minimizes handling and yields a more consistent level of sample clarity compared to traditional techniques. With the adoption of Xpressor™, laboratories have reported a decrease in the number of glove changes, a reduction in contamination risk, improved traceability concerning the original chain-of-custody tubes, and significant savings in processing time for each sample.

Additionally, the utilization of Xpressor™ is expected to lead to reduced sample loss and lower consumption of laboratory materials, thereby supporting cost control and sustainability objectives.

"Xpressor reflects our belief that meaningful progress in oral fluid testing begins by improving the steps that happen before analysis, said Ali Safavi, President and CEO of Alps Dx. He highlighted that this innovation is a critical component of their connected approach to modernizing the preanalytical continuum in oral fluid testing. In combination with their automated processing platform, Atelier™ by Alps Dx, Xpressor™ aims to decrease manual handling while enhancing efficiency, consistency, and confidence in testing outcomes.

Visitors to the Alps Dx booth at ADLM 2026 will also have the chance to learn about the Atelier™** platform, which is designed to automate the preanalytical stage of diagnostic testing. Atelier™ optimizes labor-intensive sample handling and preparation processes, thereby improving efficiency while mitigating human error. Its subscription-based model allows laboratories to scale their operations without incurring upfront capital expenses.

The introduction of Xpressor™ is part of Alps Dx's larger agenda to provide a comprehensive range of instruments, consumables, software workflows, and mobile technologies that facilitate the entire journey of an oral fluid sample—from collection to laboratory analysis.

About Alps Dx

Alps Dx specializes in developing automated and integrated technologies that advance oral fluid testing workflows across various settings, from laboratories to decentralized environments. Their product assortment is designed to enhance operational continuity, scalability, and overall efficiency within the oral fluid testing pipeline. The company is headquartered in Richmond, Virginia, with more information available at alpsdx.com.